AstraZeneca Pharma India Limited — Others, 01-08-2025: News Verification

AstraZeneca Pharma India Limited has addressed market inquiries concerning a news report about global AstraZeneca and US pricing negotiations. The company has clarified that the news item, which discussed "Trump Tariff News" and pressure on companies to cut US prices, does not pertain to AstraZeneca Pharma India Limited. The company confirmed it is not involved in any such negotiations and is unaware of any information that could impact its share price related to this news. This communication is crucial for investors to understand that the global development does not affect the operations or financial standing of the Indian listed entity.